While the weight loss effect from GLP-1 agonists has been well established [[8], [9], [10]], there were only modest effects of weight loss on knee osteoarthritis symptoms, and little effect on structural improvement [7,32,33], likely due to limited reversibility in established osteoarthritis. Here, GLP1R is linked to osteoarthritis.